Bifogade filer
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
2024-04-30 14:24:00
Redeye reviews Medivir's fourth quarter report, which presented another improvement of median time to progression for fostrox, now at 7 months. The way forward with the planned phase IIb study has also been updated after a type C meeting with the FDA.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/